In vitro and in vivo preclinical studies of NaA nanozeolite functionalized with antibodies anti-PSMA and labeled with radium radioizotope for targeted prostate cancer therapy

This project is a research project funded by the National Science Centre (NCN) - the 10^th edition of the OPUS. The project is coordinated by the Institute of Nuclear Chemistry and Technology (Warsaw, Poland) and is realized in cooperation with the National Center for Nuclear Research (Swierk - Poland) and with dr Giulio Fracasso (the Verona University, Italy). The main aim of this project is in vitro and in vivo evaluation of anti-PSMA-functionalized NaA nanozeolites labeled with the alpha-emitter 223Ra as a new radio-immunoconjugate for targeted therapy of prostate cancer.